Awridian has a proven track record with a range of groups across Drug Discovery, these include start-ups, small bio-techs, pharmaceutical companies, and academics.
Areas of expertise are illustrated by publications and presentations which include topics such as new modalities, open innovation in drug discovery, the evolving landscape of charity sector’s engagement with drug discovery along with screening compound, fragments and building block design and acquisition.
move your project forward by identifying a supplier of the required service for
example chemistry (arrays, test compound, fragments, or intermediates) or biological
assays (in vitro, in vivo and DMPK). Furthermore, Awridian recognises
that acquiring the appropriate compounds either for hit
identification projects, or for larger projects such as refreshing your
screening collection is critical. In addition Awridian can advise on the
tractability of Medicinal Chemistry Projects and how to enhance your
chance of success.
Please call or email to discuss your requirements.